HOME >> MEDICINE >> NEWS
Researchers identify leukemia-linked pathway targeted by a new kinase inhibitor

BAR HARBOR, MAINE--Three years ago, using the first of a new class of drugs known as "small molecule kinase inhibitors," medicine slammed shut a door used by cancer. Researchers at The Jackson Laboratory just found another door that kinase inhibitors may close to cancer.

The gene BCR-ABL1 causes two types of leukemia: chronic myelogeneous leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). In both cancers, enzymes that should regulate the growth and development of white blood cells go awry, resulting in uncontrolled growth of the cells. The Swiss-based pharmaceutical company Novartis developed Gleevec, the first kinase inhibitor used to fight cancer by blocking the errant enzyme. It proved effective against chronic phase of CML, but not the advanced phase or against B-ALL. In some patients, it seems CML can develop a resistance to Gleevec.

In the May 2004 issue of Nature Genetics, a research team headed by Shaoguang Li, M.D., Ph.D., of The Jackson Laboratory, announces success with another kinase inhibitor that blocks a different path used by cancer. Studying mice, the researchers discovered that the BCR-ABL1 gene activates three additional enzymes that lead to B-ALL leukemia. One of these enzymes may also be involved when CML patients no longer respond to Gleevec.

"Because of drug resistance, it becomes increasingly difficult to stop progression of and cure this disease by targeting at only one place in a multi-molecule-involved signaling pathway used by cancer," says Dr. Li. "So we needed to find a combined drug therapy targeting simultaneously more than one places in the pathway."

First, the team developed the first efficient and accurate mouse models of both forms of BCR-ABL1-induced leukemia. Next, they discovered that three of the Src kinase class of enzymes are required for B-ALL but not for CML, suggesting that different therapeutic strategies should be used for treating these two diseases although they are induced
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
18-Apr-2004


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
(Date:7/29/2015)... ... July 30, 2015 , ... Macro Wealth Management ... through the Smile for a Lifetime program by encouraging their clients to donate their ... by MWM Presidents Dr. Mart McClellan and Tim Streid, who see charitable giving as ...
(Date:7/29/2015)... ... July 30, 2015 , ... In their continuing drive ... of online continuing education courses for Athletic Trainers , HomeCEUConnection.com, today announced ... and Education Sports Medicine Series. , The new online continuing education courses were ...
(Date:7/29/2015)... ... July 29, 2015 , ... If you’re a fan of Vietnamese banh mi ... by the Orange County Register , more than 465,000 pounds of mislabeled meat ... article does not mention any reported illnesses that have been connected to problems reportedly ...
(Date:7/29/2015)... ... 2015 , ... Sports fans young and old at the National Cherry Festival ... Detroit Lions, joined by A Forever Recovery, a holistic treatment center for substance abuse ... Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob Rubick signed foam footballs, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by economists for the ... may be able to unlock mysteries about the behavior of microbial life on earth, ... and Columbia University. , The findings, published July 29 in the open access journal ...
Breaking Medicine News(10 mins):Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 3Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3
(Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
(Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7
Cached News: